Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

New China Life Insurance - A (601336.SS)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (Rmb) Price Target (Rmb) Rating
2021-08-2040.3849.60Neutral
2021-11-1638.6640.70Neutral
2022-03-3034.9336.70Neutral
2022-08-1627.6730.00Neutral
2023-02-0330.4543.90Buy
2023-04-2838.8546.30Buy
2023-08-1642.7949.60Buy
2023-11-0732.8444.70Buy
2024-03-2929.8243.50Buy
2024-10-3148.0157.10Buy

Disclosures

  • Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
  • UBS Securities Hong Kong Limited is a market maker in the Hong Kong-listed securities of this company.
  • Market capitalisation is calculated by multiplying the current share price by the sum of A and H shares.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.